文献速递生殖医学

两种IVF培养基对同胞卵母细胞囊胚形成率的比较:一项基于证据的工作流程

Blastulation rates of sibling oocytes in two IVF culture media: an evidence-based workflow to implement newly commercialized products.
PubMed 文献 · Reprod Biomed Online · 2020-11-04

该研究在≤42岁、使用射出精子、获卵4-8枚的ICSI周期中,将同胞卵母细胞随机分配至新型Geri培养基或连续单培养基(CSCM)培养。共纳入181个同胞卵母细胞队列,两组囊胚形成率相似(42.8%±30.1% vs 43.1%±29.0%,P=0.77),但Geri组囊胚发育时序更长且质量较差(26% vs 18%,P=0.03),整倍体率和持续种植率无差异。

要点

  • 同胞卵母细胞设计可快速可靠地验证新商业化培养基的性能。
  • Geri与CSCM的囊胚形成率相似,但Geri囊胚形态质量较低且发育时序延长。
  • 两种培养基的整倍体率和持续种植率无显著差异。

核心结论

  • 在同 incubator 内培养的同胞卵母细胞队列中,囊胚形成率是验证新商业化培养基的快速、可靠且全面的性能指标。
  • 本研究所测试的两种培养基效率相似,但囊胚形态和发育时序的差异值得进一步研究。

研究设计与样本

  • 非干预性同胞卵母细胞研究,纳入年龄≤42岁、使用射出精子、获卵4-8枚的ICSI周期。
  • 同胞卵母细胞随机分配至新型Geri培养基或连续单培养基(CSCM)培养。
  • 主要结局为每队列受精卵母细胞的囊胚形成率;需1182枚卵母细胞以检测7%差异(power=80%)。
  • 共纳入181个同胞卵母细胞队列,Geri组631枚卵母细胞,CSCM组643枚卵母细胞。

主要发现

  • Geri组与CSCM组囊胚形成率相似(均值±SD:42.8%±30.1% vs 43.1%±29.0%;Wilcoxon符号秩检验P=0.77)。
  • Geri组囊胚(n=275)与CSCM组(n=277)相比,着床前发育时序更长(P<0.01)且质量较差(26% vs 18%;P=0.03)。
  • 在行PGT-A的周期(n=113)中,整倍体率无差异(117/237 [49%] vs 117/249 [47%];P=0.6)。
  • 整倍体移植后持续种植率相似(29/47 [63%] vs 14/34 [41%];P=0.1),未检测移植后亦相似(12/31 [39%] vs 7/18 [39%];P=0.3)。

关键数值与推荐

  • 囊胚形成率:Geri组42.8%±30.1%,CSCM组43.1%±29.0%(P=0.77)。
  • 囊胚质量较差比例:Geri组26%,CSCM组18%(P=0.03)。
  • 整倍体率:Geri组49%(117/237),CSCM组47%(117/249)(P=0.6)。
  • 持续种植率(整倍体移植):Geri组63%(29/47),CSCM组41%(14/34)(P=0.1)。
  • 持续种植率(未检测移植):Geri组39%(12/31),CSCM组39%(7/18)(P=0.3)。

临床怎么用

  • 可采用同胞卵母细胞队列的囊胚形成率作为新培养基性能的快速验证指标。
  • 选择培养基时需权衡囊胚形成率相似但形态质量和发育时序的潜在差异。
  • 整倍体率和持续种植率相似提示两种培养基的临床效率相当。

局限性

  • 研究为非干预性设计,样本限于≤42岁、获卵4-8枚的ICSI周期,外推需谨慎。
  • 囊胚形态和发育时序差异的机制未明,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: An evidence-based novel commercially available continuous IVF culture medium in compliance with an efficient quality-management system is proposed. DESIGN: Non-interventional study on sibling oocytes. Intracytoplasmic sperm injection cycles among women aged 42 years or younger that used ejaculated spermatozoa and retrieved four to eight oocytes were included. Sibling oocytes were randomized for culture in the novel Geri-medium or continuous single culture medium (CSCM). Primary outcome measure was blastulation rate per cohort of inseminated oocytes; 1182 oocytes were required to outline down to a 7% difference (power = 80%). RESULTS: A total of 181 cohorts of sibling oocytes were included. Geri-medium (n = 631 oocytes) and CSCM (n = 643 oocytes) resulted in similar blastulation rates (mean ± SD: 42.8% ± 30.1% versus 43.1% ± 29.0%; Wilcoxon signed rank test = 0.77). Blastocysts cultured in the former (n = 275 versus n = 277) showed longer timings during preimplantation development (P < 0.01) and were poorer quality (26% versus 18%; P = 0.03). Euploidy rate was no different in cycles that underwent preimplantation genetic testing for aneuploidy (n = 113) (117/237 [49%] versus 117/249 blastocysts [47%]; P = 0.6). Ongoing implantation rate was comparable in the study arms after euploid (29/47 [63%] versus 14/ 34 [41%]; P = 0.1) or untested (12/31 [39%] versus 7/18 [39%]; P = 0.3) transfers. CONCLUSION: Blastulation rate among cohorts of sibling oocytes cultured in the same incubator is a fast, reliable and comprehensive performance indicator to validate novel commercially available culture medium. The media tested were considered similarly efficient. The differences in blastocyst morphology and developmental timings warrant further investigation, although euploidy and ongoing implantation rates were similar.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Fabozzi G, Albricci L, Cimadomo D, et al. Blastulation rates of sibling oocytes in two IVF culture media: an evidence-based workflow to implement newly commercialized products. Reprod Biomed Online. 2020. PMID: 33288477. doi:10.1016/j.rbmo.2020.10.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。